ImmunityBio stockIBRX
ImmunityBio trades at $8.01, 35.6% below its 52-week high (Feb 25, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +304.5% year to date, +272.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for IBRX — after you log in
Open the terminalFrequently asked questions about ImmunityBio
What is the ImmunityBio stock price?
At the close on Nov 5, 2026: $8.01 (−10.30% on the day). 52-week high: $12.43 on Feb 25, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does ImmunityBio report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −120% year over year, revenue +94%.
Does ImmunityBio pay dividends?
No, ImmunityBio does not pay dividends.
Where does ImmunityBio trade and how to buy it?
Ticker IBRX, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy ImmunityBio now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for IBRX are in the terminal after you log in.